Bruno Lucidi
At a glance: Bruno Lucidi is Director at Atea Pharmaceuticals (AVIR). Their latest SEC Form 4, filed Nov 19, 2026, reported a sale of $27K. On file: 0 purchase lines ($0) and 2 sale lines ($116K).
Disclosed holdings: about $737K of AVIR stock: 187,990 shares reported on their latest Form 4 (filed Nov 19, 2026), valued at the Nov 20, 2026 close of $3.92. This counts only AVIR shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Atea Pharmaceuticals, Inc. (AVIR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Bruno Lucidi's InsiderPrint
2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (0)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
Follow Bruno Lucidi
Get one email when Bruno Lucidi files a new purchase or sale. Free.
At most one email a day about Bruno Lucidi, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.